Uncover key drivers, emerging technologies, and competitive movements shaping the intraoperative neuromonitoring (ionm) market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Veterinary Parasiticides Market reach by 2030 starting from 2026 levels?

The veterinary parasiticides market has experienced robust expansion in recent years. It is forecast to increase from $15.53 billion in 2025 to $16.36 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.4%. The historical rise in this market was driven by the high occurrence of parasitic infections in livestock, the extensive use of conventional dewormers, the growth of commercial animal farming, the rising number of veterinary prescriptions for parasite management, and the presence of basic oral and injectable parasiticides.

The veterinary parasiticides market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $20.22 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.4%. This anticipated growth during the forecast period is primarily driven by factors such as an increase in pet ownership and focus on companion animal care, heightened awareness regarding zoonotic parasite risks, an uptake in preventive veterinary healthcare practices, the creation of innovative parasiticide formulations, and the broadening reach of veterinary clinic networks. Key trends defining this period encompass a surging demand for broad-spectrum parasiticides, greater acceptance of combination and endectocide products, an expansion of preventive parasite control initiatives, a sharpened focus on managing parasites in companion animals, and the increasing application of long-acting and sustained-release formulations.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2457&type=smp

Which Drivers Are Influencing Long-Term Growth In The Veterinary Parasiticides Market?

The global veterinary parasiticides market is anticipated to expand due to the increasing worldwide adoption of pets. Pet adoption involves giving a domesticated animal, often from a shelter, rescue group, or former owner, a stable and caring forever home. Owners who adopt pets often demonstrate greater responsibility and health awareness, resulting in increased demand for parasiticides to safeguard their animals from common parasites and ensure their health. Animal shelters and rescue groups frequently initiate parasite prevention, thereby encouraging the continued use of such products. For example, data from April 2025 by the Canadian Animal Health Institute, a trade association located in Canada, indicated that in 2024, approximately 7.2 million dogs and 8.2 million cats resided in Canada, establishing pets as a key component of over half of Canadian households. Consequently, the expanding trend of pet adoption is boosting the veterinary parasiticides market’s expansion.

Which Segments Are Driving Activity In The Veterinary Parasiticides Market?

The veterinary parasiticides market covered in this report is segmented –

1) By Type: Endoparasiticides, Ectoparasiticides, Endectocides

2) By Formulation: Oral Liquids, Tablets, Injectables, Sprays, Other Formulations

3) By Application: Farm Animals, Companion Animals

4) By End Users: R&D Facilities, Farms, Veterinary Clinics

Subsegments:

1) By Endoparasiticides: Anthelmintics (Dewormers), Antiprotozoals, Anticestodals, Antitrematodals

2) By Ectoparasiticides: Insecticides, Acaricides, Repellents

3) By Endectocides: Ivermectin-based Products

What Trends Are Reshaping The Dynamics Of The Veterinary Parasiticides Market?

Leading companies within the **veterinary parasiticides market** are concentrating on developing innovative solutions, such as long-acting injectable and broad-spectrum parasiticide formulations. This initiative aims to address the increasing demand for extended protection against various parasite species, improve compliance among pet owners, reduce treatment frequency, and provide comprehensive parasite control for companion animals and livestock, especially as awareness of zoonotic diseases and animal health needs rises. These long-acting injectable and broad-spectrum formulations are designed to maintain therapeutic levels of active ingredients over extended periods, offering defense against fleas, ticks, and internal parasites with a **single administration**, which significantly enhances convenience compared to traditional **monthly** oral or spot-on products that necessitate more frequent dosing and can lead to compliance challenges. For instance, in **February 2025**, **Merck Animal Health**, a **US-based** animal health company, highlighted the injectable formulation of **BRAVECTO (fluralaner)**. This parasiticide delivers up to **12 months** of continuous flea and tick protection with a **single dose**, providing veterinarians and pet owners with a highly convenient and effective preventative choice. This formulation sustains effective concentrations of **fluralaner** throughout the **year**, thereby minimizing missed doses, simplifying parasite management, and supporting animal welfare by reducing the need for repetitive treatments. The product’s extended-release mechanism and **year-long** duration represent a considerable advancement over conventional parasiticides, which often require **monthly or quarterly** applications, consequently improving long-term parasite control and adherence to treatment protocols.

Which Major Firms Are Strengthening Their Position In The Veterinary Parasiticides Market?

Major companies operating in the veterinary parasiticides market are Bayer AG, Zoetis Inc., Boehringer Ingelheim, Merck & Co. Inc., Ceva Animal Health, Dechra Pharmaceuticals plc, Phibro Animal Health Corporation, Bovian Health Care Pvt Ltd, Norbrook Laboratories Limited, Bimeda Holdings PLC, PetIQ Inc., ECO Animal Health Group plc, Bioniche Animal Health Canada Inc., Laboratorios Hipra SA, Elanco Animal Health Incorporated, Virbac, Huvepharma, Chanelle Pharma, Zydus Animal Health, KRKA d d

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/veterinary-parasiticides-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Veterinary Parasiticides Market?

North America was the largest region in the veterinary parasiticides market in 2025. Asia-Pacific was the second-largest region in the veterinary parasiticides market. The regions covered in the veterinary parasiticides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Veterinary Parasiticides Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2457&type=smp

Browse Through More Reports Similar to the Global Veterinary Parasiticides Market 2026, By The Business Research Company

Veterinary Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Veterinary Infectious Disease Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Veterinary Antibiotics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company